TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Develops and manufactures IV solutions, vaccines, and other human medical products.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA

Description

TURK İLAÇ VE SERUM SANAYİ A.Ş. is a pharmaceutical company engaged in the development, manufacturing, and sale of human medical products. The company's core business revolves around the production of IV Parenteral Solutions (serum), operating a high-capacity manufacturing facility that establishes it as a major supplier. In addition to serum, its portfolio includes a variety of other essential pharmaceuticals such as vaccines, ampoules, vials, and tablets. The company has also established a significant presence in biotechnology with the development of an integrated vaccine production facility.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 14:36
Finansman Bonosu İtfası Hakkında
English 18.0 KB
2025-08-04 08:24
Satışın Tamamlanması Hakkında
English 18.2 KB
2025-07-30 14:01
Borçlanma Aracı İhracı Hk.
English 17.9 KB
2025-07-30 07:57
Bağımsız Denetim Firması Hakkında
Turkish 29.1 KB
2025-07-30 07:51
Kayıtlı Sermaye Tavanı ve Süre Uzatımı Tescili Hakkında.
Turkish 1.6 MB
2025-07-30 07:51
Kayıtlı Sermaye Tavanı ve Süre Uzatımı Tescili Hakkında.
Turkish 7.1 KB
2025-07-30 07:48
Olağan Genel Kurul Tescili Hakkında.
Turkish 47.5 KB
2025-07-30 07:48
Olağan Genel Kurul Tescili Hakkında.
Turkish 148.8 KB
2025-07-30 07:48
Olağan Genel Kurul Tescili Hakkında.
Turkish 281.6 KB
2025-07-30 07:48
Olağan Genel Kurul Tescili Hakkında.
Turkish 145.7 KB
2025-07-30 07:48
Olağan Genel Kurul Tescili Hakkında.
Turkish 148.4 KB
2025-07-30 07:48
Olağan Genel Kurul Tescili Hakkında.
Turkish 30.6 KB
2025-07-04 15:41
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-06-30 14:53
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-06-26 11:08
Devlet Malzeme Ofisi İhale Sonucu
English 42.2 KB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TURK İLAÇ VE SERUM SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.